Clinical Case Studies

Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Functional MRI brain maps of resting-state functional connectivity in representative age- and sex-matched participants
News | Magnetic Resonance Imaging (MRI)
Light Therapy Increases Brain Connectivity Following Injury

May 31, 2024 — Low-level light therapy appears to affect healing in the brains of people who suffered significant brain ...

Time May 31, 2024
arrow
IceCure Medical Ltd. has announced that the Food and Drug Administration (FDA) has granted its appeal and reopened its De Novo Classification Request for Marketing Authorization of its ProSense cryoablation technology for early-stage breast cancer.
News | FDA
FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense for Early-Stage Breast Cancer

January 30, 2024 — IceCure Medical Ltd. has announced the U.S. Food and Drug Administration (FDA) has responded ...

Time January 30, 2024
arrow
UCLA investigators present the latest cancer research at the American Society of Clinical Oncology annual meeting June 2 to June 6 in Chicago
News | Radiation Oncology
Targeted Therapy for Early Breast Cancer, Progress Treating Recurrent Glioma, PSMA PET Scan Advances Research Presented

May 22, 2023 — Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest ...

Time May 22, 2023
arrow
Parametric maps of amyloid deposition in healthy control participants (A and B) and blast-exposed military instructors (C and D) at baseline (A and C) and follow-up (B and D). The blue-to-red scale indicates the frequency of statistically abnormal amyloid uptake in a particular brain voxel. Whereas no abnormal amyloid uptake was identified at baseline or follow-up in healthy control participants (A, B), amyloid deposition occurred most frequently in blast-exposed participants in the superior parietal lobule
News | PET Imaging
Recurrent Brain Trauma May Increase Alzheimer’s Risk

May 22, 2023 — New research finds that the brains of otherwise healthy military personnel who are exposed to explosions ...

Time May 22, 2023
arrow
Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital in China
News | Radiation Therapy
TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...

Time February 16, 2023
arrow
Study highlights gender disparity in how frequently doctors and clinical trials assess the impact of treatment on sexual health
News | Clinical Case Studies
Sexual Side Effects of Cancer Treatment Often Unaddressed with Female Patients

October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with ...

Time October 21, 2022
arrow
18F-SMBT-1 PET studies showed that beta-amyloid+ Alzheimer’s disease (AD) patients, but most importantly, beta-amyloid+ controls (CN) have significantly higher regional 18F-SMBT-1 binding than beta-amyloid- CN, with 18F-SMBT-1 retention highly associated with beta-amyloid burden. These findings suggest that increased 18F-SMBT-1 binding is detectable at the preclinical stages of beta-amyloid accumulation.
News | PET Imaging
Novel PET Imaging Agent Detects Earliest Signs of Alzheimer's Disease

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...

Time October 20, 2022
arrow
(From left): Pengfei Song, a researcher at the Beckman Institute and a professor of electrical and computer engineering and bioengineering; Matthew Lowerison, a Beckman Institute Postdoctoral Fellow; and Zhijie Dong, a Ph.D. student in the Song Lab, are members of an interdisciplinary, multi-institute team that received NIH funding to develop a new device that can instantly add 3D capabilities to 2D ultrasound imaging systems. Their affordable, user-friendly design could help make high-quality medical imagi
News | Ultrasound Imaging
Interdisciplinary Researchers Receive $2M to Develop Next-Generation 3D Ultrasound Imaging Device

October 13, 2022 — A new device in the works at the Beckman Institute for Advanced Science and Technology could make ...

Time October 13, 2022
arrow
A new study published by University of Kentucky Markey Cancer Center researchers suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.
News | Radiation Oncology
Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy

August 15, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 15, 2022
arrow
The authors used a questionnaire to collect in three rural districts data on symptoms and clinical characteristics after COVID-19, with the focus on symptoms after 12 weeks.
News | Coronavirus (COVID-19)
The Effects of Long COVID

June 27, 2022 — Three articles and an accompanying editorial provide information on the effects of Long COVID in the ...

Time June 28, 2022
arrow
William van Kampen, Xoran Chief Technology Officer and principal investigator on the project.
News | Lung Imaging
Xoran Technologies Starts Work on Phase 2 of Mobile Lung CT NIH Grant

June 24, 2022 — Xoran Technologies announced they have begun work on Phase 2 of their mobile lung grant with the goal to ...

Time June 24, 2022
arrow
SIR Foundation launched a program to enhance the scientific rigor of research into interventional radiology treatments, devices and techniques through mentorship, during the SIR 2022 Annual Scientific Meeting in Boston.
News | SIR
SIR Foundation Launches New Network to Foster IR Research

June 20, 2022 — SIR Foundation launched a program to enhance the scientific rigor of research into interventional ...

Time June 20, 2022
arrow
Platform displayed within additional image series to interpreting radiologist
News | Artificial Intelligence
AI Saves One Hour of Daily Chest CT Interpretation Time in Prospective Randomized Study

June 14, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), incorporating AI support into clinical ...

Time June 14, 2022
arrow
The current shortage of iodinated contrast in the United States due to the COVID-19 related production shutdown in China is causing severe disruptions in patient care. A new Harvey L. Neiman Health Policy Institute study outlines the most frequently used computed tomography (CT) services performed on Medicare beneficiaries as focus areas for mitigation strategies for the greatest overall impact.
News | Contrast Media
New Study Informs Mitigation Strategies for Contrast Shortage in CT by Identifying Promising Areas of Focus

June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production ...

Time June 01, 2022
arrow
Oral presentation based on Late-breaking Abstract featured at American Urological Association’s 2022 Annual Meeting (AUA2022)
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA

May 16, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time May 16, 2022
arrow
Prof. Dr. Samer Ezziddin, image courtesy of Thorsten Mohr/Saarland University
News | Prostate Cancer
New Radiotracer Yields Huge Increase in Accuracy of Localizing Prostate Cancer relapses

April 15, 2022 — Prostate cancer is the most common malignant tumor in men in Germany, with about 62,000 new cases ...

Time April 14, 2022
arrow
T2w images with overlays of lesion boundaries, DWI-derived ADC, DCE-derived 𝐾𝑡𝑟𝑎𝑛𝑠, and CDI𝑠 for six patient cases. (a, b) Two patients with csPCa in the PZ. (c, d) Two patients with csPCa in the TZ. (e) A patient with csPCa in the PZ and insPCa in the TZ. (f) A patient with csPCa in the AS and insPCa in the PZ.
News | Magnetic Resonance Imaging (MRI)
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See

March 28, 2022 — A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could ...

Time March 28, 2022
arrow
Axial T1-weighted (A) and STIR (B) images depict denervation edemalike signal of extensor muscles of dorsal and mobile wad compartments with no fatty infiltration or atrophy consistent with NS-RADS M1.
News | Magnetic Resonance Imaging (MRI)
Neuropathy Score Reporting and Data System (NS-RADS) Validated for MR Neurography

March 4, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), a new reporting and data ...

Time March 04, 2022
arrow
A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.
News | Radiation Therapy
Experimental Combinatorial Therapy Eliminates an Incurable Brain Tumor

February 22, 2022 — A study recently accepted for publication in The Journal of Clinical Investigation describes a new ...

Time February 22, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now